Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02008370 · ClinicalTrials.gov registry record · Phase 4
Exparel in Minimally Invasive Cardiac Surgery
A Phase 4 study, sponsored by Maimonides Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT02008370: Clinical Trial Phase 4 study, sponsored by Maimonides Medical Center.
NCT02008370 is a Phase 4 study that was terminated before completion, run by Maimonides Medical Center. The registered enrollment target is 9 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02008370, a Phase 4 study, was terminated before completion, sponsored by Maimonides Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
The investigators are presently using Exparel, a slow released local anesthestic, in patients undergoing minimally invasive cardiac surgery. The primary objective of this study is to assess the efficacy of EXPAREL when delivered into the thoracotomy and chest tube sites to provide prolonged postoperative analgesia in patients undergoing minimally invasive cardiac surgery. Efficacy will be assessed by: the effectiveness of analgesia as measured by the subject's overall postoperative pain scores and postsurgical analgesic use.
Primary Outcome
The other primary endpoint of this study is the effectiveness of analgesia from the thoracotomy and chest tube site infiltrations as measured by the overall postsurgical analgesic use, (converted to morphine equivalents).
Interventions
- DRUG Exparel infiltration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2013-11 |
| Est. Completion | 2016-06 |
| Phase | Phase 4 |
Why NCT02008370 stopped before completion
NCT02008370 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Exparel infiltration is the first listed.
NCT02008370 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02008370 about?
NCT02008370 is a clinical study titled "Exparel in Minimally Invasive Cardiac Surgery". The investigators are presently using Exparel, a slow released local anesthestic, in patients undergoing minimally invasive cardiac surgery. The primary objective of this study is to assess the efficacy of EXPAREL when delivered into the thoracotomy and chest tube sites to provide prolonged postoper...
What is the current status of trial NCT02008370?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2013-11. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02008370?
The interventions under investigation include: Exparel infiltration (DRUG).
Who is sponsoring clinical trial NCT02008370?
This trial is sponsored by Maimonides Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02008370's enrollment target sits among peer trials
9 1968th of 2000 higher than 29 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia